RISANKIZUMAB for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 1,051 adverse event reports in the FDA FAERS database where RISANKIZUMAB was used for Psoriasis.
Most Reported Side Effects for RISANKIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product storage error | 396 | 15.0% | 0 | 3 |
| Drug ineffective | 206 | 7.8% | 2 | 40 |
| Psoriasis | 138 | 5.2% | 2 | 25 |
| Crohn's disease | 103 | 3.9% | 1 | 23 |
| Arthralgia | 100 | 3.8% | 2 | 13 |
| Off label use | 100 | 3.8% | 1 | 9 |
| Product temperature excursion issue | 88 | 3.3% | 0 | 1 |
| Diarrhoea | 72 | 2.7% | 1 | 7 |
| Fatigue | 70 | 2.7% | 0 | 4 |
| Rash | 64 | 2.4% | 1 | 10 |
| Pruritus | 61 | 2.3% | 0 | 12 |
| Headache | 58 | 2.2% | 2 | 13 |
| Therapeutic product effect decreased | 56 | 2.1% | 0 | 11 |
| Abdominal pain | 50 | 1.9% | 0 | 28 |
| Urticaria | 49 | 1.9% | 0 | 1 |
Other Indications for RISANKIZUMAB
Crohn's disease (863)
Product used for unknown indication (340)
Colitis ulcerative (162)
Psoriatic arthropathy (161)
Generalised pustular psoriasis (18)
Inflammatory bowel disease (14)
Pustular psoriasis (14)
Maternal exposure timing unspecified (8)
Rheumatoid arthritis (7)
Skin disorder (7)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)